Developer of non-invasive molecular diagnostic therapies. The company is focused on biomarker discovery and development through to industrial prototyping, final product design and pivotal clinical trials, then licensing its products to large pharmaceutical companies for commercialization.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Merger/Acquisition | 08-Feb-2013 | 00.000 | Completed | Product Development | ||
1. Early Stage VC | 17-Feb-2011 | 00.000 | 00.000 | Completed | Product Development |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Julia Winter | Chief Executive Officer |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
ACC1Ó | Government | Minority | 000 0000 | 000000 0 | |
Inveready Technology Investment Group | Venture Capital | Minority | 000 0000 | 000000 0 | |
Ministry of Science and Innovation | Government | Minority | 000 0000 | 000000 0 |